Tribalto M - Search Results

1

The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years after.

Pulsoni A, Avvisati G, Petrucci MT, Mandelli F, Giannarelli D, Lauta VM, Tribalto M, Pileri A. Pulsoni A, et al. Among authors: tribalto m. Blood. 1998 Sep 15;92(6):2184-6. Blood. 1998. PMID: 9731081 Free article. No abstract available.

2

Biology and treatment of multiple myeloma.

Mandelli F, Avvisati G, Tribalto M. Mandelli F, et al. Among authors: tribalto m. Curr Opin Oncol. 1992 Feb;4(1):73-86. doi: 10.1097/00001622-199202000-00010. Curr Opin Oncol. 1992. PMID: 1591296 Review.

3

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

Mandelli F, Avvisati G, Amadori S, Boccadoro M, Gernone A, Lauta VM, Marmont F, Petrucci MT, Tribalto M, Vegna ML, et al. Mandelli F, et al. Among authors: tribalto m. N Engl J Med. 1990 May 17;322(20):1430-4. doi: 10.1056/NEJM199005173222005. N Engl J Med. 1990. PMID: 2184356 Free article. Clinical Trial.

4

Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.

Avvisati G, Petrucci MT, Pulsoni A, Tribalto M, Lauta VM, Gernone A, Boccadoro M, Marmont F, Pileri A, Dammacco F, et al. Avvisati G, et al. Among authors: tribalto m. Eur J Haematol Suppl. 1990;52:9-11. doi: 10.1111/j.1600-0609.1990.tb00897.x. Eur J Haematol Suppl. 1990. PMID: 2279547 Clinical Trial. No abstract available.

5

[Therapy of multiple myeloma and its complications].

Avvisati G, Pulsoni A, Petrucci MT, Tribalto M. Avvisati G, et al. Among authors: tribalto m. Recenti Prog Med. 1990 Oct;81(10):642-50. Recenti Prog Med. 1990. PMID: 2291008 Review. Italian.

6

Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.

Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F. Tribalto M, et al. Haematologica. 2000 Jan;85(1):52-8. Haematologica. 2000. PMID: 10629592 Clinical Trial.

7

Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment.

Petrucci MT, Avvisati G, Tribalto M, Cantonetti M, Giovangrossi P, Mandelli F. Petrucci MT, et al. Among authors: tribalto m. Eur J Haematol. 1989 Mar;42(3):233-7. doi: 10.1111/j.1600-0609.1989.tb00104.x. Eur J Haematol. 1989. PMID: 2924885

8

[Current aspects of treatment of multiple myeloma].

Tribalto M, Avvisati G, Cantonetti M, Catalano G, Giovangrossi P, Masi M, Petrucci MT, Venditti A, Papa G. Tribalto M, et al. Ann Ital Med Int. 1988 Jul-Sep;3(3):193-202. Ann Ital Med Int. 1988. PMID: 3152856 Review. Italian. No abstract available.

9

Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.

Mandelli F, Tribalto M, Avvisati G, Cantonetti M, Petrucci MT, Boccadoro M, Pileri A, Marmont F, Resegotti L, Lauta V, et al. Mandelli F, et al. Among authors: tribalto m. Cancer Treat Rev. 1988 Jan;15 Suppl A:43-8. doi: 10.1016/0305-7372(88)90073-4. Cancer Treat Rev. 1988. PMID: 3277709 Clinical Trial. No abstract available.

10

Classification of patients affected by multiple myeloma using a neural network software.

Bugliosi R, Tribalto M, Avvisati G, Boccardoro M, de Martinis C, Friera R, Mandelli F, Pileri A, Papa G. Bugliosi R, et al. Among authors: tribalto m. Eur J Haematol. 1994 Mar;52(3):182-3. doi: 10.1111/j.1600-0609.1994.tb01312.x. Eur J Haematol. 1994. PMID: 8168599 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page